Symbol | Exchange | Currency |
|---|
Nov 13 (Reuters) - Neimeth International Pharmaceuticals PLC NEIMETH.LG : * QTRLY PROFIT BEFORE TAX 128.7 MILLION NAIRA VERSUS 235.2MILLIONNAIRA * QTRLY TURNOVER 1 BILLION NAIRA...
(Adds index close) By Chijioke Ohuocha ABUJA, Nov 11 (Reuters) - Nigerian stocks climbed to a morethan two-year high on Wednesday as domestic funds bought sharesacross sectors and...
May 11 (Reuters) - Neimeth International Pharmaceuticals PLC NEIMETH.LG : * QTRLY LOSS BEFORE TAX 26.1 MILLION NAIRA VERSUS PROFIT OF144.5MILLION NAIRA * QTRLY TURNOVER 558.7...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Neutral | Strong Sell | Buy |
| Technical Indicators | Sell | Sell | Strong Buy | Strong Sell | Buy |
| Summary | Strong Sell | Sell | Buy | Strong Sell | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 23.25 | 23.40 | 23.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 5.70 | 6.00 | 5.65 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 19.05 | 19.05 | 19.05 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 0.20 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 7.30 | 7.30 | 7.20 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 216.90 | 215.00 | 215.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 29.55 | 30.00 | 29.55 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 76.85 | 78.90 | 73.95 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 19.90 | 19.90 | 19.90 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 29.00 | 29.00 | 29.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 5.35 | 5.30 | 5.30 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 46.50 | 45.10 | 45.00 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 8.40 | 8.50 | 8.30 | 0.00 | 0.00% | 0.00 | Lagos | |||
| 2.03 | 2.03 | 2.03 | 0.000 | 0.00% | 0.00 | Lagos | |||
| 0.31 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | Lagos |
Neimeth International Pharmaceuticals Plc is engaged in manufacturing and marketing of pharmaceuticals and animal health products. The Company operates through two segments: Pharmaceuticals product group and Animal health product group. The Company manufactures, markets and distributes Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables and oral liquid forms. Pharmaceuticals product group is engaged in the marketing and sales of the Company's branded products and the products under the consumer product group. Animal health product group is engaged in the marketing and sales of poultry and animal range of anthelmintics, as well as production medicaments. Its products include Consumer Products, Ethical Products and Natural Products. Its Consumer Products include Antimal, NimARTEM, Hemafolin and pancemol. Its Ethical Products include Norduet, Flexodene, and Ciklavit. It operates in two geographic regions: Nigeria and Ghana.